Skip to main content
Thomas Ollila, MD, Oncology, Providence, RI

Thomas A Ollila MD

Hematologic Oncology


Physician

Join to View Full Profile
  • 593 Eddy StProvidence, RI 02903

  • Phone+1 401-444-9375

Dr. Ollila is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Rhode Island Hospital/Brown University Health
    Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 2012 - 2015
  • Drexel University College of Medicine
    Drexel University College of MedicineClass of 2012

Certifications & Licensure

  • RI State Medical License
    RI State Medical License 2012 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Bendamustine-Rituximab Does Not Improve Survival over Rituximab Monotherapy for Older Patients with Nodal or Splenic Marginal Zone Lymphoma
    Thomas A Ollila, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Tumor-Specific Cell-Free DNA (cfDNA) in the Cerebrospinal Fluid (CSF) Detects Cytologically Occult Central Nervous System (CNS) Involvement in Aggressive Lymphomas
    Thomas A Ollila, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Exposure to Ibritumomab Tiuxetan and Incidence of Treatment-Related Myeloid Neoplasms Among Older Patients with B-Cell Lymphoma: A Population-Based Study
    Thomas A Ollila, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Radiation therapy in primary testicular lymphoma (PTL): Does practice match the standard of care? 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Lifespan Study Looks at Antibody Levels in Some Fully Vaccinated Cancer Patients
    Lifespan Study Looks at Antibody Levels in Some Fully Vaccinated Cancer PatientsAugust 17th, 2021

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: